
Cerner closes its Kantar Health acquisition, sets sights on life sciences
Cerner on Thursday announced the completion of its purchase of Kantar Health for $375 million in cash – an acquisition it says will be a boost to its expanded efforts toward life sciences research capabilities. WHY IT MATTERS Kantar Health’s analytics expertise spans a wide array of therapeutic areas: Alzheimer’s, cancers, rare diseases and more. Its tools and policy expertise […]
Read more